These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19661287)

  • 41. [Receptors for oreksins: structure, localisation and activation mechanisms].
    Abramova TV; Perekrest SV; Shainidze KZ; Novikova NS; Korneva EA
    Ross Fiziol Zh Im I M Sechenova; 2011 Sep; 97(9):995-1007. PubMed ID: 22165210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization of the orexin system in the gastrointestinal tract of fallow deer.
    Dall'Aglio C; Pascucci L; Mercati F; Boiti C; Ceccarelli P
    Acta Histochem; 2012 Feb; 114(2):74-8. PubMed ID: 21397934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intra-paragigantocellularis lateralis injection of orexin-A has an antinociceptive effect on hot plate and formalin tests in rat.
    Erami E; Azhdari-Zarmehri H; Ghasemi-Dashkhasan E; Esmaeili MH; Semnanian S
    Brain Res; 2012 Oct; 1478():16-23. PubMed ID: 22906776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential gene expression and immune localization of the orexin system in the major salivary glands of pigs.
    Dall'Aglio C; Zannoni A; Mercati F; Forni M; Bacci ML; Boiti C
    Regul Pept; 2011 Dec; 172(1-3):51-7. PubMed ID: 21888930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presence, distribution and steroidogenic effect of the peptides orexin A and receptor 1 for orexins in the testis of the South American camelid alpaca (Vicugna pacos).
    Liguori G; Assisi L; Squillacioti C; Paino S; Mirabella N; Vittoria A
    Gen Comp Endocrinol; 2012 Oct; 179(1):137-42. PubMed ID: 22909972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation.
    Patsoukis N; Duke-Cohan JS; Chaudhri A; Aksoylar HI; Wang Q; Council A; Berg A; Freeman GJ; Boussiotis VA
    Commun Biol; 2020 Mar; 3(1):128. PubMed ID: 32184441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice.
    Mihara Y; Dohi K; Yofu S; Nakamachi T; Ohtaki H; Shioda S; Aruga T
    J Mol Neurosci; 2011 Feb; 43(2):162-8. PubMed ID: 20803175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716.
    Hilairet S; Bouaboula M; Carrière D; Le Fur G; Casellas P
    J Biol Chem; 2003 Jun; 278(26):23731-7. PubMed ID: 12690115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orexin A upregulates the protein expression of OX1R and enhances the proliferation of SGC-7901 gastric cancer cells through the ERK signaling pathway.
    Liu Y; Zhao Y; Ju S; Guo L
    Int J Mol Med; 2015 Feb; 35(2):539-45. PubMed ID: 25515760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis.
    Alexandre D; Hautot C; Mehio M; Jeandel L; Courel M; Voisin T; Couvineau A; Gobet F; Leprince J; Pfister C; Anouar Y; Chartrel N
    Eur J Cancer; 2014 Aug; 50(12):2126-33. PubMed ID: 24910418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
    Robinson JD; McDonald PH
    Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role.
    Couvineau A; Dayot S; Nicole P; Gratio V; Rebours V; Couvelard A; Voisin T
    Front Endocrinol (Lausanne); 2018; 9():573. PubMed ID: 30319552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling.
    Rouault AAJ; Lee AA; Sebag JA
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2322-2329. PubMed ID: 28939058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid identification of orexin receptor binding ligands using cell-based screening accelerated with magnetic beads.
    Qi X; Astle J; Kodadek T
    Mol Biosyst; 2010 Jan; 6(1):102-7. PubMed ID: 20024071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of a functional allatotropin receptor in the bumblebee, Bombus terrestris (Hymenoptera, Apidae).
    Verlinden H; Lismont E; Bil M; Urlacher E; Mercer A; Vanden Broeck J; Huybrechts R
    Gen Comp Endocrinol; 2013 Nov; 193():193-200. PubMed ID: 23968772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of orexin A and its receptor 1 in the epididymis of the South American camelid alpaca (Vicugna pacos).
    Liguori G; Paino S; Mirabella N; Squillacioti C; De Luca A; Vittoria A
    Anat Histol Embryol; 2014 Feb; 43(1):42-7. PubMed ID: 23521689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists.
    Nagahara T; Saitoh T; Kutsumura N; Irukayama-Tomobe Y; Ogawa Y; Kuroda D; Gouda H; Kumagai H; Fujii H; Yanagisawa M; Nagase H
    J Med Chem; 2015 Oct; 58(20):7931-7. PubMed ID: 26267383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disruption of 5-hydroxytryptamine 1A receptor and orexin receptor 1 heterodimer formation affects novel G protein-dependent signaling pathways and has antidepressant effects in vivo.
    Zhang R; Li D; Mao H; Wei X; Xu M; Zhang S; Jiang Y; Wang C; Xin Q; Chen X; Li G; Ji B; Yan M; Cai X; Dong B; Randeva HS; Liu C; Chen J
    Transl Psychiatry; 2022 Mar; 12(1):122. PubMed ID: 35338110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations.
    Wang Q; Zhao WC; Fu XQ; Zheng QC
    Front Chem; 2020; 8():597495. PubMed ID: 33330386
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Dayot S; Speisky D; Couvelard A; Bourgoin P; Gratio V; Cros J; Rebours V; Sauvanet A; Bedossa P; Paradis V; Ruszniewski P; Couvineau A; Voisin T
    Oncotarget; 2018 Jan; 9(6):6952-6967. PubMed ID: 29467942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.